The mixed-lineage kinase 3 inhibitor URMC-099 facilitates microglial amyloid-β degradation
about
Amelioration of amyloid-β-induced deficits by DcR3 in an Alzheimer's disease model.Autophagy facilitates macrophage depots of sustained-release nanoformulated antiretroviral drugsMixed-lineage kinase 3 pharmacological inhibition attenuates murine nonalcoholic steatohepatitis.Mixed Lineage Kinase 3 Mediates the Induction of CXCL10 by a STAT1-Dependent Mechanism During Hepatocyte Lipotoxicity.Anti-retroviral drugs: current state and development in the next decade.URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer's disease.
P2860
The mixed-lineage kinase 3 inhibitor URMC-099 facilitates microglial amyloid-β degradation
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The mixed-lineage kinase 3 inh ...... croglial amyloid-β degradation
@en
The mixed-lineage kinase 3 inh ...... roglial amyloid-β degradation.
@nl
type
label
The mixed-lineage kinase 3 inh ...... croglial amyloid-β degradation
@en
The mixed-lineage kinase 3 inh ...... roglial amyloid-β degradation.
@nl
prefLabel
The mixed-lineage kinase 3 inh ...... croglial amyloid-β degradation
@en
The mixed-lineage kinase 3 inh ...... roglial amyloid-β degradation.
@nl
P2093
P2860
P1476
The mixed-lineage kinase 3 inh ...... croglial amyloid-β degradation
@en
P2093
Bhagyalaxmi Dyavarshetty
Howard E Gendelman
Sarah M Whitmire
Tomomi Kiyota
Weiguo Dong
P2860
P2888
P356
10.1186/S12974-016-0646-Z
P577
2016-07-11T00:00:00Z
P6179
1005413352